While these immunostaining studies of lung specimens derived from six SCLC patients and six healthy individuals lack a sufficiently large number of samples to draw definitive conclusions, our initial pilot data suggests DARPP-32 isoforms are aberrantly overexpressed in human SCLC and additional comprehensive immunohistochemistry studies are warranted. Here, PPP1R1B is linked to small cell lung carcinoma.